RecruitingPhase 2NCT06670534

A Dose-finding Study of JMKX003142 in Treatment of Renal Edema

A Multicenter,Randomized,Open-label,Positive-controlled Study to Evaluate the Efficacy and Safety of JMKX003142 in Renal Edema Patients

Sponsor

Jemincare

Enrollment

216 participants

Start Date

Jan 7, 2025

Study Type

INTERVENTIONAL

Conditions

Edema Secondary Edema Leg

Summary

To Evaluate the Safety, Efficacy, and Pharmacokinetic Characteristics of JMKX003142 Administered Randomly, Open-label, Active-controlled Study in Chinese Renal Edema Patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called JMKX003142 tablets and a drug called Torasemide tablets for people with edema leg and edema secondary. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGJMKX003142 tablets

JMKX003142 tablets for experimental groups.Take the JMKX003142 tablets（on empty stomach） once daily for seven days.

DRUGTorasemide tablets

Torasemide tablets for active comparator group.Take the torasemide tablets once daily for seven days.

Locations(2)

Fudan University Affiliated Zhongshan Hospital

Shanghai, China

Zhejiang Hangyu Pharmaceutical Co., Ltd（subsidiary of Jemincare）

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06670534

Related Trials

Extracorporeal Shock Wave Therapy in Lower Extremity Lymphedema

NCT07626645

Does Edema Affect the Adjustment of TENS Amplitude

NCT061532771 location